Bangalore, Aug 5, 2007: Daiichi Sankyo has finally been permitted by SEBI and FIPB board to launch an open offer buy 20 percent stake in Ranbaxy held by retail investors and financial institutions.

 

Securities and Exchange Board of India (SEBI) is the market regulator whose approval is needed in India to enhance, acquire or merge companies. It looks after investors’ interests as well.

 

FIPB is the Foreign Investment Promotion Board hat looks after foreign companies investment in Indian companies and India.